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Abstract
Background: We performed a systematic review to assess the effect of integrated perinatal prevention of mother-to-child
transmission of HIV interventions compared to non- or partially integrated services on the uptake in low- and middle-
income countries.
Methods: We searched for experimental, quasi-experimental and controlled observational studies in any language from 21
databases and grey literature sources.
Results: Out of 28 654 citations retrieved, five studies met our inclusion criteria. A cluster randomized controlled trial
reported higher probability of nevirapine uptake at the labor wards implementing HIV testing and structured nevirapine
adherence assessment (RRR 1.37, bootstrapped 95% CI, 1.04–1.77). A stepped wedge design study showed marked
improvement in antiretroviral therapy (ART) enrolment (44.4% versus 25.3%, p,0.001) and initiation (32.9% versus 14.4%,
p,0.001) in integrated care, but the median gestational age of ART initiation (27.1 versus 27.7 weeks, p=0.4), ART duration
(10.8 versus 10.0 weeks, p=0.3) or 90 days ART retention (87.8% versus 91.3%, p=0.3) did not differ significantly. A cohort
study reported no significant difference either in the ART coverage (55% versus 48% versus 47%, p=0.29) or eight weeks of
ART duration before the delivery (50% versus 42% versus 52%; p=0.96) between integrated, proximal and distal partially
integrated care. Two before and after studies assessed the impact of integration on HIV testing uptake in antenatal care. The
first study reported that significantly more women received information on PMTCT (92% versus 77%, p,0.001), were tested
(76% versus 62%, p,0.001) and learned their HIV status (66% versus 55%, p,0.001) after integration. The second study also
reported significant increase in HIV testing uptake after integration (98.8% versus 52.6%, p,0.001).
Conclusion: Limited, non-generalizable evidence supports the effectiveness of integrated PMTCT programs. More research
measuring coverage and other relevant outcomes is urgently needed to inform the design of services delivering PMTCT
programs.
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Introduction
At the United Nations General Assembly Special Session
(UNGASS) in 2001, a goal was set to reduce by 2010 the
proportion of HIV infected infants by 50%. Achieving this target
would require that an estimated 80% of pregnant women and
their children need to receive essential HIV prevention, treatment
and care [1].
Women represent slightly more than 50% of HIV infected
population [2]. Each day, an estimated 1000 children under the
age of 15 acquire HIV infection [2]. More than 90% of HIV
infections in children under the age of 15 are due to mother-to-
child transmission (MTCT) of HIV and more than 90% of the
mother to child transmission occurs in sub-Saharan Africa [2].
Transmission of HIV from mother-to-child can be reduced from
15–40% to 1% through effective prevention of mother-to-child
transmission of HIV (PMTCT) programs [3].
When PMTCT programs were initially introduced in low- and
middle-income countries, they were stand-alone programs, with
gradual integration into maternal and newborn healthcare services
[4,5]. The rationale for integrating PMTCT interventions with
other healthcare services is to improve access for women and
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  , Hoda Elmoniry ,children and increase the quality of care through better and
synergistic use of human and financial resources. Furthermore,
implementing a PMTCT program as a part of routine healthcare
helps reduce the stigma experienced by HIV infected people [6–
8]. However, many women in low- and middle-income countries
lack access to maternal and child healthcare services [9].
Furthermore, even pregnant women attending maternal and child
healthcare services are often not reached by all requisite
interventions of the PMTCT programs integrated with these
services. Additionally, integration could overburden already weak
healthcare services in resource-limited countries. Lack of resourc-
es, leadership and monitoring could have a negative impact on the
implementation and sustainability of the integrated services.
Integration could also lead to increased stigmatization towards
the healthcare services providing PMTCT interventions and
clients attending those services [10,11].
The existing integrated PMTCT programs experience attrition
at each step of the program delivery: from the first contact,
through counseling, testing, collecting results, receiving antiretro-
viral therapy (ART), infant treatment and feeding recommenda-
tion and postnatal follow-up; thereby reducing program effective-
ness [12–14]. Based on data from a multi-country PMTCT
program implemented by the Elizabeth Glaser Pediatric AIDS
Foundation in 2006, of 100 pregnant women that attend antenatal
clinic, 92 are counseled, 77 are tested for HIV and 69 receive test
results. Of eight women identified as HIV positive, six receive
ARV prophylaxis. Of infants born to these eight HIV positive
women identified, only four will receive prophylaxis [15]. In 2009,
only an estimated 26% of pregnant women in low- and middle-
income countries were tested for HIV and an estimated 53%
[40%–79%] of them received antiretroviral medication to prevent
the mother-to-child transmission of HIV [12]. In 11 of the 25
countries with the largest numbers of women needing prophylaxis
with antiretroviral medicines to reduce mother-to-child transmis-
sion, coverage levels were below 50% [12].
Integration of PMTCT with other healthcare services is a
crucial component of the strategy to scale up PMTCT programs
[12,16–18]. However, there is no universally accepted definition of
integrated care [19–23]. ‘‘Integration’’ is used to describe a range
of organizational arrangements with variable nature and intensity
[24]. Therefore, any analysis and comparison of integrated
healthcare is methodologically challenging. Research on integra-
tion of healthcare services into health systems to improve health
outcomes has been mostly focused on comparison between
integrated or horizontal versus non-integrated or vertical pro-
grams. However, it has also included additional concepts such as
diagonal or oblique programs for those programs which are
neither fully integrated nor completely vertical, acknowledging
that the extent of integration of services can vary greatly.
Furthermore, it has been accepted that integration can happen
at various levels of the health system, i.e. local, district, regional or
national and can include different health system functions such as
governance, financing, planning, service delivery, monitoring and
evaluation, and demand generation [24]. In this review, we
defined the integration of PMTCT interventions as joining of
service delivery of PMTCT programs with other healthcare
services at a single point of access [25]. We defined partially
integrated PMTCT programs as those that refer women to a
separate facility for PMTCT interventions and those that integrate
a segment of the PMTCT program compared to the intervention
arm. By non-integrated PMTCT programs, we considered
separate, detached, stand-alone PMTCT programs without any
links to or referrals from other healthcare services.
Our preliminary searches found a systematic review on
integration of sexual and reproductive health services with HIV
services produced by the WHO in 2009 [25–27]. The review,
framed around the ‘four prongs’ of PMTCT defined by WHO,
focused on integration of the first, the second and the fourth prong
of PMTCT strategies while the third prong was - very surprisingly
- excluded if the interventions were not linked to other areas of
sexual and reproductive health.
This left a substantial gap in evidence provided by this report. In
addition to this systematic review, we found several non-systematic
literature overviews [28–31]. Given the importance of the question
and weak evidence base, there is an urgent need to systematically
evaluate effectiveness of integrated compared to non- or partially
integrated PMTCT programs on the uptake of PMTCT
interventions.
Methods
Search Strategy
We performed a comprehensive search to identify peer-
reviewed academic and grey literature published between January
1990 (i.e. the year first PMTCT programs were established) and
August 2010 [32]. We used a sensitive search strategy developed in
collaboration with the Cochrane HIV/AIDS Review Group. We
used the search string in Table 1 for Medline (PubMed). Details of
the search strategies for other databases are available from the
authors.
The search strategy did not entail search terms related to
integrated care because in some studies ‘‘integration’’ could have
been omitted or labeled differently. Instead, we examined service
delivery in each study to decide if it would meet our definition of
healthcare service integration.
We searched MEDLINE, EMBASE, the Cochrane Library, the
WHO Global Health Library, CAB abstracts, CINAHL, PO-
PLINE, PsycINFO, Sociological abstracts, ERIC and U.S.
National Library of Medicine Gateway System, the WHO
International the Clinical Trials Registry and Controlled Clinical
Trials. We also searched several grey literature sources: AEGIS,
Google Scholar, New York Academy of Medicine Grey Literature,
Open SIGLE, British Library Catalogue and ProQuest Disserta-
tion & Theses Database. Google Scholar search resulted in a large
number of hits of which we scanned the first 500. Two reviewers
independently performed the searches. We screened reference lists
of included studies and relevant systematic reviews for additional
studies. We contacted authors of relevant conference proceedings
for additional information.
Eligibility Criteria
According to WHO, PMTCT consists of four prongs: 1)
primary prevention of HIV infection in women; 2) prevention of
unintended pregnancy among HIV-positive women; 3) reduction
of transmission from HIV infected pregnant and lactating women
to their children during the perinatal period, i.e. pregnancy, birth
and infant feeding and care and 4) support of women, infants, and
families infected and affected by HIV/AIDS.
Our review assessed the effect of integration of the third prong
of PMTCT measures i.e. perinatal PMTCT interventions aimed
at reducing MTCT of HIV) These consist of HIV testing of
pregnant women, reduction of viral load with antiretroviral
therapy (ART) or prophylaxis, safe delivery practices, infant
feeding counseling, infant antiretroviral (ARV) prophylaxis and
HIV testing of infants. Safe delivery practices are defined as
elective caesarean section or vaginal delivery with minimal use of
invasive procedures.
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including more than one, of the perinatal PMTCT interventions
with other healthcare services.
Eligible controls were usual care, consisting of non-integrated or
partially integrated healthcare services.
We included all study designs with a control or comparison in
order to present all existing evidence on the effectiveness of
integration of PMTCT programs. We included experimental,
quasi-experimental and controlled observational studies. While in
observational studies it is never possible to rule out unrecognized
bias with confidence, they help us understand the issues studied
[33]. Studies had to focus on pregnant women, women in labor
and postpartum and their infants, with unknown or positive HIV
status, from low- and middle-income countries as defined by the
World Bank [34], with the proportion of women and children
receiving individual PMTCT interventions as a primary outcome.
In addition, we aimed to collect other relevant outcomes such as
the cost-effectiveness and impact of integrated care on human
resources, quality of care, stigma and attendance of services
integrated with PMTCT. We included studies in any language.
Our review was informed by a Cochrane review we did in parallel
with the Cochrane HIV/AIDS Group [35]. There were several
differences between this and the review registered with the
Cochrane Collaboration: type of the included studies, quality
assessment tools, analysis of the data etc. The protocol peer-review
performed by the Cochrane Collaboration helped us with this
review. In particular in relation to the study which met Cochrane
criteria (one study) [36,37].
Screening Process, Data Extraction and Synthesis
Two review authors independently performed screening of the
citations and data extraction. Disagreements between authors
were resolved by discussion, consensus and consultation with a
third review author. Citations were downloaded into bibliographic
management software (EndNote X4). We screened the titles and
abstracts and then full-texts of the studies for eligibility. We
extracted data from the included studies using a standardized data
extraction sheet, which summarized key information from the
relevant studies, such as administrative data, methodology,
information on participants, interventions, outcomes, comparison
and other notes. Statistical pooling of results was not feasible due
to heterogeneity of reported interventions, outcomes and study
designs. Therefore, we present the findings narratively.
Quality Assessment
Two review authors separately performed the assessment of the
quality of the evidence. Any differences of opinion were resolved
by discussion and in consultation with the third review author.
We used a three-point scale examining the suitability of the study
design. This was adapted from the criteria used for the Community
GuideoftheUSTaskForceonCommunityPreventiveServices[38].
For randomized controlled trials, controlled clinical trials,
cluster randomized controlled trials, controlled before and after
studies and interrupted time series, we used the risk of bias tool
developed by the Cochrane Collaboration [39–41]. Each criterion
had to be rated as either yes (low risk of bias), unclear (uncertain
risk of bias), or no (high risk of bias).
We evaluated other study designs by a six-item checklist of
criteria developed for the Effective Public Health Practice Project
in Hamilton, Ontario [42], as adapted by Thomas et al. [43]. This
quality assessment tool evaluates representativeness, randomiza-
tion, comparability, credibility of data collection instruments,
attrition rate and attributability to intervention.
Results
We identified 28 654 citations. Five studies met the inclusion
criteria (Table S1) [36,37,44–46]. One study was reported twice, in
the form of a journal article and thesis [36,37]. The study selection
processispresentedintheformofanadaptedPRISMAflow-diagram
(Figure1).Wewillfirstpresentthedescriptionoftheincludedstudies,
their quality assessment and types of interventions and then the
reported outcomes, i.e. the uptake ofintegrated interventions.
Description of Included Studies
The studies were conducted in sub-Saharan Africa: a cluster
randomized controlled trial and a stepped wedge design evaluation
in Zambia [37,46], a before and after study in Kenya [44], a
before and after study in Malawi [45], and a retrospective cohort
study in South Africa [47]. All studies were conducted in low-
income countries apart from the South-African study (an upper-
middle income country).
Quality Assessment
The suitability of study design (Table S2 and Table S3) was
rated as A for one study [37], B for two studies [46,47], and C for
two studies [44,45].
The included cluster randomized controlled trial had a low risk
of bias (Table S2). Of the remaining studies, one study met five
[46], one study met four [47], and other two studies met two of the
six quality assessment criteria (Table S3) [44,45].
Interventions
The studies were conducted in different periods between 2001
and 2008, in urban settings except for one study set in rural
Malawi [45]. The included studies evaluated the effectiveness of
Table 1. Search strategy MEDLINE (PubMed).
#1 Search HIV Infections[MeSH] OR HIV[MeSH] OR hiv[tw] OR hiv-1*[tw] OR hiv-2*[tw] OR hiv1[tw] OR hiv2[tw] OR hiv infect*[tw] OR human immunodeficiency virus[tw]
OR human immunedeficiency virus[tw] OR human immuno-deficiency virus[tw] OR human immune-deficiency virus[tw] OR ((human immun*) AND (deficiency
virus[tw])) OR acquired immunodeficiency syndrome[tw] OR acquired immunedeficiency syndrome[tw] OR acquired immuno-deficiency syndrome[tw] OR acquired
immune-deficiency syndrome[tw] OR ((acquired immun*) AND (deficiency syndrome[tw])) OR ‘‘sexually transmitted diseases, viral:noexp’’[MH]
#2 Search mother-to-child[tiab] OR MTCT[tiab] OR mother-to-infant[tiab] OR adult-to-child[tiab] OR maternal-to-child[tiab] OR vertical transmission[tiab] OR perinatal
transmission[tiab] OR postnatal transmission[tiab] OR post natal transmission[tiab] OR maternal-infant transmission[tiab] OR PMTCT[tiab] OR infectious disease
transmission, vertical/prevention and control[mh]
#3 Search #1 AND #2
#4 Search (#1 AND #2) NOT (animals[mh] NOT humans[mh])
#5 Search (#1 AND #2) NOT (animals[mh] NOT humans[mh]) Limits: Publication Date from 1990/01/01 to 2010/07/26
doi:10.1371/journal.pone.0035268.t001
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labor ward [37], integration of ART provision [46,47] or HIV
testing and counseling with antenatal care [44,45].
Integration of HIV Testing in Antenatal Care
We found one study from Kenya and one from Malawi that
provided data before and after the integration of HIV testing
within antenatal care [44,45]. In both studies, opt-in rapid testing
was used.
In a Kenyan program, PMTCT interventions were first
partially integrated in antenatal care. Women received general
information on the PMTCT program in antenatal care [44]. They
were then referred for counseling and implementation of the
PMTCT steps to a counselor located in a separate room in the
Figure 1. Flow-diagram of the study selection process.
doi:10.1371/journal.pone.0035268.g001
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antenatal tests including HIV testing. Women identified as HIV
positive had to see the counselor again at 34 weeks of gestation to
receive nevirapine for both themselves and their infants. Women
who came to the labor ward were asked if they took nevirapine
and given a new dose, if necessary. All infants born to HIV positive
mothers at the hospital received nevirapine. In the following,
intervention period, women were tested in a side laboratory in the
antenatal care. The same nurse-counselor provided counseling,
HIV testing, post-test HIV counseling and routine antenatal care
preventive interventions [44].
In the Malawian program, HIV counseling and testing were
offered at a voluntary counseling and testing center, located in the
outpatient department. Subsequently, HIV testing and counseling
were integrated with antenatal care. Nevirapine was provided to
women and infants at labor ward before and after the integration
[45].
Integration of HIV Testing and Structured Nevirapine
Assessment with Labor Ward Care
The cluster randomized controlled trial included 7664 women
delivering in 12 public-sector delivery centers in Lusaka, Zambia.
Six clinics were randomly assigned to the intervention arm and six
to the control arm. Midwifes implemented the services [37].
At the intervention sites, women of unknown serostatus received
opt-in rapid HIV testing at the labour ward and nevirapine tablet
(200 mg) if identified as HIV positive. HIV seronegative women
were offered a calcium tablet to avoid disclosure of the HIV status
and potential stigmatization of HIV positive women. Previously
identified HIV positive women were provided with nevirapine in
antenatal care and were administered a structured nevirapine
adherence assessment at the labor ward. They were informed
about the purpose of nevirapine and were asked if they were
prepared to receive it at the labor ward. If women did not ingest
the prophylaxis and had indicated their willingness to take it at the
labor ward, they received nevirapine in the labor ward.
At the control clinics, only previously identified HIV positive
women received nevirapine in the labor ward if they did not take
the tablet provided in antenatal care. To establish their adherence,
midwifes would informally ask if they had taken the nevirapine.
All infants born to HIV positive mothers had to be provided
with nevirapine syrup (2 mg/kg) in both the control and
interventional clinics before hospital discharge.
The primary outcome of the study was maternal-infant
nevirapine coverage. Maternal coverage was determined by the
nevirapine testing of the umbilical cord blood specimens collected
anonymously. Infant coverage was determined based on the report
of nevirapine administration in the patient’s record. The maternal-
infant nevirapine coverage was measured in both control and
interventional clinics at baseline and intervention period.
Integration of ART Provision with Antenatal Care
A stepped wedge evaluation from Zambia and a retrospective
observational study from South Africa evaluated integration of
ART (i.e. highly active antiretroviral therapy (HAART)) provision
in antenatal care [46,47].
The Zambian stepped wedge design study compared the
integration of the ART provision in antenatal clinics and referral
to local ART clinics [46]. The data was collected from the same
eight antenatal clinics before and after the roll-out of integrated
care.
HIV positive women with CD4 cell counts less than or equal to
250 cells/ml were eligible for ART. In the pre-intervention period,
eight antenatal sites referred ART eligible women attending
antenatal care to ART clinics. ART clinics and antenatal care
were located at the same healthcare facility. Peer educators
provided additional education to ART eligible women and
accompanied them to the ART clinic.
In the intervention period, antenatal clinics started providing
ART in antenatal care. The intervention was rolled-out gradually
with one new site every month. Antenatal care provided ART
services one to two days per week. Both control and intervention
clinics used the same schedule of visits, laboratory evaluations,
record systems, and quality assurance systems. The same cadre of
providers worked before and after the intervention: a clinical
officer, a nurse, and a peer educator.
The South African retrospective cohort study compared three
different models of integrated care [47]. In one facility, a doctor
provided ART twice per week (i.e. integrated care). In another
facility, women were referred from antenatal care to the HIV
clinic located in a different building but in the same healthcare
facility (i.e. proximal partially integrated service). In the last two
clinics, women were referred to the HIV clinic situated in a
different healthcare center not more than 5 km away from the
antenatal care clinic (i.e. distal partially integrated service).
Women with CD4 cell counts equal to or less than 200 cells/ml
were considered eligible for ART. All antenatal care facilities
routinely performed HIV counseling with opt-in testing and
prophylaxis for mothers and infants.
Outcomes
HIV testing in antenatal care. The two before and after
studies that assessed integration of HIV testing in antenatal care
reported significant increases in testing uptake after the integration
[44,45].
In the Kenyan before and after study, significantly more women
received information on PMTCT (92% versus 77%, p,0.001),
were tested (76% versus 62%, p,0.001) and learned their status
(66% versus 55%, p,0.001) when comparing the intervention
(n=4089) and the control group (n=4142) [44].
In the Malawian before and after study, the proportion of
pregnant women who were tested significantly increased from
52.6% before the integration (n=196) to 78.7% after the
integration (n=1063), (p,0.001) [45].
The full integration of the ART provision in antenatal care did
not have a significant impact on the testing uptake in the Zambian
stepped wedge study (97.9% versus 98.4%, p=0.51) [46].
Nevirapine coverage. In the Zambian cluster randomized
controlled trial, the proportion of mother-infant pairs receiving
nevirapine at the control sites declined from 53% in the baseline
period to 43% in the intervention period (range of difference in
coverage from –13% to 0%). The maternal-infant nevirapine
coverage increased from 42% to 52% (range of difference in
coverage from –10% to +33%) at the intervention sites. The
relative risk of mother-infant nevirapine coverage in the
intervention arm compared to the control was 0.89 at baseline
and 1.22 at the end of the intervention period. This change
resulted in a ratio of relative risks of 1.37 (RR 1.37, bootstrapped
95% CI, 1.04–1.77). According to the subgroup analysis assessing
the effect of each of the two implemented interventions, rapid HIV
testing at labor ward was associated with an absolute increase in
nevirapine coverage of 16% (range 4 to 25%) in the treatment
clinics (from 0% at baseline). The structured assessment of
nevirapine adherence was associated with a 4% increase in
coverage in the treatment clinics (from 63% at baseline to 67%
during the intervention period), compared to a 9% drop in
coverage in the control clinics (from 74% at baseline to 65%
during the intervention period) [37].
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of HIV testing in antenatal care on nevirapine coverage at labor
ward had mixed results. The acceptance of nevirapine at the
labor ward did not significantly change after the integration of
HIV testing (92% versus 97%, p=0.4) in the Malawian
program [45]. The Kenyan study reported a significant increase
in nevirapine uptake (57% versus 70%, p,0.001) [45].
However, in the Malawian study, nevirapine was only dispensed
at the labor ward and in the Kenyan program, nevirapine was
dispensed in both antenatal care and at the labor ward [44,45].
ART coverage, initiation and duration. In the Zambian
stepped wedge study, the proportion of women who were tested
for HIV, who underwent the CD4 count measurement and who
were eligible for ART did not differ significantly between the
control (n=716) and the intervention (n=846), (98.4% versus
97.9%, 85% versus 85.1% and 27.6% versus 26.5%, respectively).
The complete integration of ART provision in antenatal care was
associated with higher proportion of women enrolled in HIV care
(44.4% versus 25.3%, p,0.001) and provided with ART (32.9%
versus 14.4%, p,0.001) [46].
There was no significant difference between control and
intervention either in the median gestational age of ART initiation
(27.1 versus 27.7 weeks, p=0.4) or in mean weeks of ART
initiation before delivery (10.8 versus 10.0 weeks, p=0.3). Ninety
days retention in care after the initiation of ART therapy was
similar in both groups (87.8% in the intervention and 91.3% in the
control, p=0.3) [46].
In the South African cohort study, the proportion of eligible
women initiating ART in integrated (n= 227), proximal
(n=159) and distal (n=130) care did not differ significantly:
55%, 48% and 47%, respectively (p=0.29). No significant
difference was found between integrated, proximal or distal care
either in the median gestational age of initiation of ART (32
weeks (range 28–35) versus 33 weeks (range 29–36) versus 31
weeks (range 26–34), p=0.11) or the proportion of women who
stayed on ART for more than eight weeks compared to those
who received eight weeks or less of ART (50% versus 42%
versus 52%, p=0.96). The duration of ART before the delivery
was eight weeks in 48%, between four and eight weeks 32%
and less than 4 weeks in 20% of women [47].
Overall uptake of PMTCT interventions in integrated
programs. The five studies evaluated integration of a single
perinatal PMTCT intervention and reported four key outcomes:
uptake of HIV testing, nevirapine and ART, and ART initiation
and ART duration.
In the two studies evaluating integration of HIV testing into
antenatal care, the testing coverage was 76% and 79%,
respectively [44,45]. A high-quality study, cluster randomized
controlled trial, while successful in achieving a 10% increase in
nevirapine coverage fell 30% short of the 80% coverage target
[37]. In Zambian study, only 37% of eligible women enrolled into
ART care and only 24% started the therapy [46]. In South
African integrated PMTCT program, only 55% of eligible women
initiated ART, 26% received ARV prophylaxis, and 19% did not
receive any antiretroviral intervention before delivery in integrated
care [47].
Cost-effectiveness, impact on human resources, stigma
and quality of care, attendance of services integrated with
PMTCT interventions. None of the included studies compared
the cost-effectiveness, impact on human resources, stigma, quality
of care or attendance of services integrated with PMTCT
interventions between the different models of care.
Discussion
Our review shows there is very limited, non-generalizable
evidence of improved PMTCT intervention uptake in integrated
PMTCT programs. None of the included studies evaluated
integration of the whole PMTCT program. Further, the uptake
of integrated PMTCT interventions was mostly low, and did not
reach the 80% target set by UNGASS.
We found no information about the barriers to PMTCT uptake
among the participants in the included studies, although the
women’s preferences are critical in the uptake of the PMTCT
[48,49]. Two included studies [37,44] indicated related research
[50,51] on reasons for loss to follow up in integrated PMTCT
programs which reported wide range of motives ranging from lack
of staff, late labor ward presentation to fear of partner violence and
stigma. In the included Kenyan study, partners of women
participating in integrated care were also invited to counseling
and testing, but only 1% of them attended the clinic [44]. Such a
low uptake is of great concern given the impact that male
involvement could have on pregnant women’s participation in the
PMTCT programs [52].
Quality of the included studies varied from a cluster randomized
controlled trial with low risk of bias to before and after studies
meeting only two out of the six quality criteria. The included
studies were heterogeneous, presenting integration of various
PMTCT interventions in different settings. Only the Zambian
cluster randomized control trial evaluated labor ward-based
integrated PMTCT care. In this study, the control group consisted
of labor wards without the targeted PMTCT intervention (i.e.
HIV testing and structured nevirapine adherence assessment).
Other studies mostly used partially integrated care (i.e. referral to
PMTCT program) as a control. In most of the studies, women and
children in need of PMTCT intervention were referred to separate
PMTCT services in the same hospital or on the same premises
where antenatal care clinics were located [44–46]. A study with
PMTCT interventions offered either in a separate building on the
same premises as antenatal clinic or within 5-km radius [47],
showed no significant difference in intervention uptake in regards
to distance of partially integrated PMTCT services. While it is
encouraging that distances up to 5 km did not seem to be critical
with regards to uptake, both types of service delivery fell short of
the UNGASS target and as such do not answer the question of
how to organize the services effectively.
Our findings are consistent with the Cochrane review on
strategies for integrating primary health services at the point of
delivery in developing countries, which was also not able to
provide a general message about their effectiveness [19]. Assessing
effects of integration of services is not challenging just because of
lack of studies but also because of lack of comparability of
approaches. One of the key concerns regarding the integration of
PMTCT program is its impact on the quality of existing
healthcare services [53,54]. None of the included studies reported
this outcome. A recently published systematic review assessed the
impact of PMTCT integration on the quality of maternal
healthcare services and reported both positive and negative effects
and limited evidence base [53].
Several systematic reviews have assessed the effectiveness of
integration of different healthcare services. Two systematic reviews
assessing the effectiveness of linking family planning and sexual
and reproductive health with HIV/AIDS interventions reported
positive effects of integration on the uptake of HIV testing [26,27].
They also stated that the included studies only evaluated
integration at service delivery level and were not specifically
Integrated PMTCT Programs: A Systematic Review
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with the same services offered separately.
Our systematic review has a number of strengths. We undertook
an extensive search of numerous electronic databases without the
use of specific search terms for integrated care, methodological
filters or language restrictions and searched for relevant indexed
peer-reviewed academic and grey literature. We built on high-
quality, internationally recognized Cochrane systematic review
methodology and expanded the inclusion of study designs with a
greater risk of bias (observational studies) but which may provide
additional insight into ‘real-world’ effectiveness [55]. The
operational research focused on health services and health systems
often warrants alternative study designs given the complexity and
dynamic nature of these organizational units [56]. The limitations
of this review include the low number of studies of variable quality
that were highly heterogeneous, which prevented us from reaching
a conclusion on the effectiveness of different modes of integrated
PMTCT programs. However, given the complex and heteroge-
neous nature of healthcare delivery and integration, it is debatable
if research focused on these topics can in fact be sufficiently
homogenous to allow for a uniform, straightforward conclusion
about the effectiveness of integrated programs. We are also aware
that the definition of integrated healthcare we use, focused mainly
on location of service delivery, may have resulted in the omission
of other potentially relevant articles.
The question of integration may be seen as outdated since
recommendations to integrate PMTCT programs is widely
embedded into global and national policies and strategies for
fighting the HIV epidemic [18,57]. Our study, however, reveals a
highly problematic position showing that evidence base on the
effectiveness of integrated care compared to non- or partially
integrated is scarce at best, with no clarity on modality of
integration and all models failing to achieve target coverage.
While it is plausible to anticipate beneficial effects of integrated
PMTCT programs through mechanisms of improving access and
increasing uptake of PMTCT interventions; we agree with the
current guidance proposed by international health organizations
stating that future integration of PMTCT programs to other
services must carefully consider system readiness for integration
and the epidemiological context [12,17,18]. Outcomes other than
intervention coverage such as cost-effectiveness, impact on quality
of care, human resources and stigma [48,58] and the wide range of
contexts in which these programs are implemented should also be
considered [59–62]. The effectiveness of PMTCT program
delivery models depends also on HIV prevalence, health seeking
behavior and the dominant mode of horizontal HIV transmission
among attendees.
Considering the size of the problem, potential for dramatic
impact of PMTCT interventions and the corresponding scale of
investment into HIV care and prevention, policy makers must
ensure urgent prioritization of rigorous research on integration of
PMTCT.
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